All eyes will be on Sears Holdings (NYSE:SHLD) next Thursday when it reports Q3 earnings. One could call it a "multi-tiered" evaluation, as SHLD's report has meaning on several levels.
First, there's the company-specific turnaround story. Traders and analysts will want to see if the momentum from chairman Eddie Lambert's company restructuring continued in Q3. Lambert took on the difficult task of closing underperforming stores – many of which were long-standing, well-regarded stores in their communities – while also rightsizing SHLD's workforce, and integrating the acquired Kmart discount outlets.
Then there are the Sears' retail sector implications: analysts will use Sears' Q3 report as another data point/barometer regarding the U.S. retail sector's health heading into the pivotal Q4 holiday shopping season, For Q3, Sears, which traded Thursday at about $174.75, is expected to post modest flat-to-modest-growth in same store sales of about $11.8B on EPS of 98c.
Finally, there's the old economy / new economy dimension. The Sears restructuring effort serves as a case study regarding the ability of an old economy retail chain to make the transition to the new retail world of shopping online and viewing dazzling displays of products via streaming video right on your pc. Wall Street will want to see some progress regarding online traffic and sales versus Sears' primary competitors, JC Penney (JCP), Target (TGT), and Wal-Mart (WMT). A failure to show a modest improvement in online sales and traffic may give Wall Street cause for concern regarding Sears' ability to attract online shoppers in the decade ahead.
Hence, from a variety of standpoints, Sears' Q3 report next week will be awaited with keen interest, and cautious optimism, that better days are ahead for both shoppers and investors.
Post provided by Joseph Lazzaro and TheFlyOnTheWall.com (subscription required).
Last updated: February 13, 2012: 05:15 AM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


Reader Comments (Page 1 of 1)
11-09-2006 @ 9:38PM
Lee Gaupp said...
I've been holding Sears stock (based on cramer's recommendation) and I try to do the best at research. I understand that Lambert is currently the best thing going for Sears and researching SHLD and Eddie Lambert has been a real treat - making some money along the way has been cool too!
11-14-2006 @ 6:37PM
Eric said...
It's Lampert, not Lambert